Bigmar Receives FDA Approval for
Selected Abstract
Bigmar Receives FDA Approval for Daunorubicin Hydrochloride for Injection, USP; Seventh ANDA Approval in 1999.
JOHNSTOWN, OhioBUSINESS WIREJune 1, 1999-- BIGMAR, INC. (Nasdaq SmallCap Market: BGMR) today announced that it has received Abbreviated New Drug Application ( ANDA ) approval from the Food and Drug Administration ( FDA ) for Daunorubicin Hydrochloride for Injection, USP 20 mg, its seventh ANDA ... June 1, 1999; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Bigmar Receives FDA Approval for Daunorubicin Hydrochloride for Injection, USP; Seventh ANDA Approval in 1999.
2.
BIGMAR Receives FDA Approval for Fluorouracil Injection; Sixth ANDA Approval in 1999.
|
